Intellectual Property India Publishes Patent Application for Lactam Derivatives For Inhibiting Nlrp3 And Uses Thereof

MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617065172 A) filed by Ventus Therapeutics U. S. , Inc. on May 23, 2026, for Lactam Derivatives For Inhibiting Nlrp3 And Uses Thereof.

Inventors include Dorich, Stphane; and Ciblat, Stphane.

The application for the patent was published on June 12, 2026, under issue no. 24/2026.

Abstract: The present disclosure relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R3, R4, R4a, R4b, Z, R5, R6, R6', and R6", are described herein, and R7 and R2 are joined to form a 5- to 10-membered monocyclic or bicyclic heterocyclyl or 5- to 10-membered monocyclic or bicyclic heteroaryl, and methods of preparation, methods o...